Table 4.
Effects of Movement as Medicine for CVDa Prevention on health care provider outcomes (N=11).
| Outcome | Baseline, mean (SD) | Postcourse period, mean (SD) | P valueb | Cohen d (95% CI) |
| Self-efficacy | 3.91 (0.82) | 5.03 (0.98) | .002 | 1.24 (0.67 to 1.80) |
| Attitudes | 6.82 (0.34) | 6.86 (0.26) | .69 | 0.13 (−0.40 to 0.66) |
| Intention | 5.91 (0.77) | 5.86 (1.23) | .91 | −0.05 (−0.65 to 0.56) |
| Planning | 4.48 (1.42) | 5.45 (0.75) | .05 | 0.85 (−0.01 to 1.69) |
| Habit | 4.93 (1.62) | 5.55 (1.33) | .04 | 0.42 (0.02 to 0.80) |
| Goal conflictc | 3.68 (1.33) | 3.59 (1.53) | .76 | −0.06 (−0.46 to 0.34) |
aCDV: cardiovascular disease.
bP values reported are for paired t tests and are not corrected for multiple comparisons. Instead, we refer readers to the reported effect size estimates and CIs.
cFor this outcome, a negative effect size indicates a favorable result of the intervention.